Joint pricing negotiations are not only gathering pace in Europe as Latin American countries from the Mercosur trade bloc have together negotiated a lower price for trastuzumab. However, the company that markets the originator drug, Herceptin, has expressed doubts about how productive joint pricing negotiations really are in addressing access issues.
Mercosur aims to wield its collective bargaining power to tackle high medicine prices and has already announced lower prices for...







